SEC notch­es win in bio­phar­ma 'shad­ow' in­sid­er trad­ing case

The SEC won its case against a for­mer Medi­va­tion ex­ec­u­tive who bought stocks in a com­pet­ing phar­ma com­pa­ny af­ter learn­ing the con­fi­den­tial news that Medi­va­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER